Goldman Sachs’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.45M | Buy |
478,618
+285,316
| +148% | +$2.65M | ﹤0.01% | 2896 |
|
|
2025
Q1 | $1.3M | Sell |
193,302
-80,459
| -29% | -$541K | ﹤0.01% | 3644 |
|
|
2024
Q4 | $2.91M | Sell |
273,761
-294,747
| -52% | -$3.13M | ﹤0.01% | 3251 |
|
|
2024
Q3 | $8.31M | Buy |
568,508
+384,260
| +209% | +$5.62M | ﹤0.01% | 2407 |
|
|
2024
Q2 | $2.23M | Sell |
184,248
-147,516
| -44% | -$1.78M | ﹤0.01% | 3130 |
|
|
2024
Q1 | $8.19M | Buy |
+331,764
| New | +$8.19M | ﹤0.01% | 2209 |
|